Shares of Schrödinger, Inc. (NASDAQ:SDGR – Get Free Report) have received a consensus rating of “Moderate Buy” from the ten analysts that are covering the stock, MarketBeat Ratings reports. Three investment analysts have rated the stock with a hold recommendation, six have issued a buy recommendation and one has given a strong buy recommendation to the company. The average twelve-month price target among brokers that have updated their coverage on the stock in the last year is $33.44.
SDGR has been the topic of a number of research reports. Leerink Partnrs upgraded Schrödinger to a “strong-buy” rating in a research report on Tuesday, July 2nd. KeyCorp cut their target price on Schrödinger from $30.00 to $25.00 and set an “overweight” rating on the stock in a report on Thursday, July 11th. Leerink Partners assumed coverage on Schrödinger in a report on Tuesday, July 2nd. They set an “outperform” rating and a $29.00 target price on the stock. Finally, Morgan Stanley cut their target price on Schrödinger from $43.00 to $30.00 and set an “equal weight” rating on the stock in a report on Wednesday, August 21st.
Get Our Latest Research Report on SDGR
Institutional Inflows and Outflows
Schrödinger Stock Down 3.0 %
Shares of SDGR stock opened at $16.98 on Thursday. The firm has a market capitalization of $1.23 billion, a P/E ratio of -9.03 and a beta of 1.50. Schrödinger has a twelve month low of $16.93 and a twelve month high of $38.00. The stock’s fifty day simple moving average is $19.79 and its 200 day simple moving average is $21.80.
Schrödinger (NASDAQ:SDGR – Get Free Report) last issued its quarterly earnings data on Wednesday, July 31st. The company reported ($0.74) earnings per share for the quarter, topping analysts’ consensus estimates of ($0.85) by $0.11. The business had revenue of $47.33 million for the quarter, compared to analyst estimates of $40.19 million. Schrödinger had a negative return on equity of 38.38% and a negative net margin of 100.42%. As a group, equities research analysts expect that Schrödinger will post -2.19 EPS for the current fiscal year.
Schrödinger Company Profile
Schrödinger, Inc, together with its subsidiaries, develops physics-based computational platform that enables discovery of novel molecules for drug development and materials applications. The company operates in two segments, Software and Drug Discovery. The Software segment is focused on licensing its software to transform molecular discovery for life sciences and materials science industries.
Featured Articles
- Five stocks we like better than Schrödinger
- Best Aerospace Stocks Investing
- Ciena Stock Powers the AI Cloud Boom—Don’t Miss Out
- Stock Dividend Cuts Happen Are You Ready?
- Affirm’s Path to Profitability Elevates with Interest Rate Cuts
- Business Services Stocks Investing
- RPM International Thrives in Rate-Cut Driven Construction Rally
Receive News & Ratings for Schrödinger Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Schrödinger and related companies with MarketBeat.com's FREE daily email newsletter.